Peripheral blood progenitor cell collection without close monitoring of peripheral blood CD34+ cells: A feasible strategy for multiple myeloma or pre-treated Non-Hodgkin’s Lymphoma patients mobilized with low-dose cyclophosphamide plus G-CSF
Author:
Publisher
Elsevier BV
Subject
Hematology
Reference24 articles.
1. G-CSF alone vs. cyclophosphamide plus G-CSF in peripheral blood PBPC mobilization of patients with lymphoma: results depend on degree of previous treatment;Milone;Bone Marrow Transplant,2003
2. Mobilization of PBPCs with high-dose cyclophosphamide or the DHAP regimen plus G-CSF in NHL;Pavone;Bone Marrow Transplant,2002
3. Effective CD34+ stem cell mobilization with low-dose pegfilgrastim;Pardee;J Appl Res,2006
4. High-dose versus low-dose cyclophosphamide in combination with G-CSF for peripheral blood progenitor cell mobilization;Ahn;Kor J Internal Med,2005
5. Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignances;Ketterer;Brit J Haematol,1998
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Clinical and equipment-related factors associated with the adequate peripheral blood stem cell collection in autologous transplant at a tertiary cancer center in Kerala - A retrospective cohort study;Transfusion and Apheresis Science;2019-08
2. Intermediate-dose cytarabine plus G-CSF as mobilization regimen for newly diagnosed multiple myeloma and heavily pre-treated patients with hematological and non-hematological malignancies;Transfusion and Apheresis Science;2019-06
3. Current status of art mobilization in Myeloma;Transfusion and Apheresis Science;2017-12
4. Peripheral Blood Progenitor Cell Mobilization for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation;Biology of Blood and Marrow Transplantation;2014-09
5. Risk factors for unsuccessful peripheral blood stem cell harvesting using granulocyte-colony stimulating factor mobilization in patients with multiple myeloma;Transfusion and Apheresis Science;2012-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3